batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Time for Gilead to cut magrolimab loose 16 February 2024 Merrimack’s lesson in humility 15 February 2024 Blueprint raises Ayvakit expectations 15 February 2024 Roche runs from Repare 13 February 2024 Foghorn gets an all-clear from Lilly 12 February 2024 After Dreamm-7, how about more multiple myeloma conjugates? 9 February 2024 Astra's next wave goes beyond subcutaneous Imfinzi 8 February 2024 BioNTech bails out Autolus 8 February 2024 Load More